Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia
Meta-analysis / review
Abstract
This updated meta-analysis of clinical trials found the Serenoa repens extract Permixon improved peak urinary flow and reduced nocturia versus placebo in symptomatic benign prostatic hyperplasia.
Referenced for these plants
How to cite
Boyle, P., Robertson, C., Lowe, F. and Roehrborn, C (2004) 'Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia', BJU International, 93(6), pp. 751-756. doi:10.1111/j.1464-410X.2003.04735.x
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.